Armed with positive results in two phase 3 trials, MSD is poised to be the first drugmaker to file for approval of an oral PCSK9 inhibitor for lowering cholesterol. Top-line results from the CORALreef ...
MSD's efforts to combine cancer immunotherapy Keytruda with its AstraZeneca-partnered PARP drug Lynparza have so far failed – but at last it can point to a partial win in a phase 3 trial. The new data ...
The majority of other information websites display prices from a single source, most of the time from one retail broker-dealer. At FXStreet, traders get interbank rates coming from a systematic ...
Abstract: Unsupervised feature selection plays a crucial role in dealing with unlabeled high-dimensional data. However, traditional unsupervised feature selection methods have some limitations. They ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback